ESC Professional Premium Access

Three decades of lipid-lowering therapy in type 2 diabetic patients with angiographically proven stable coronary artery disease

Congress Presentation

About the speakers

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)
17 presentations
2 followers

Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)
3 presentations
0 follower

7 more presentations in this session

Placebo-controlled efficacy of 17 anti-anginal drugs and percutaneous coronary intervention for first-line treatment of stable angina: systematic review & meta-analysis of 5153 patients from 53 trials

Speaker: Doctor A. Kaura (London, GB)

Thumbnail

Persistent angina following revascularization for chronic coronary syndromes: a systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor A. Singh (Los Angeles, US)

Thumbnail

Comparative meta-analysis: drug-coated balloon versus drug-coated stent - a comprehensive evaluation of efficacy and safety in stentless percutaneous coronary intervention for coronary artery disease

Thumbnail

Effect of primary pci in asymptomatic stemi patients presenting 12 to 48 hours of symptom onset, on myocardial viability assessed by spect tc 99m sestamibi scan epitome99

Speaker: Doctor M. Pandit (Bangalore, India, IN)

Thumbnail

Impact of symptom-to-balloon time on long-term prognosis: a 3-year follow-up study in non-st-segment elevation myocardial infarction patients with complex lesions

Speaker: Professor Y. Kim (Chuncheon, KR)

Thumbnail

Access the full session

Medical and percutaneous treatment of coronary artery disease

Speakers: Professor H. Drexel, Doctor A. Mader, Doctor A. Kaura, Doctor A. Singh, Doctor M. Pandit...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations